-transparent.png){kind=logo}
Human genes MAGE-1 and MAGE-3 code for antigens that are recognized on melanoma cells by autologous cytolytic T lymphocytes. These antigens may constitute useful targets for specific anti-tumor immunization of cancer patients, since genes MAGE-1 and MAGE-3 are expressed in a number of tumors of different histological types, but are not expressed in normal adult tissues other than testis. This also applies to genes MAGE-2 and MAGE-4, which are closely related to MAGE-1 and MAGE-3. We have analyzed the expression of these 4 MAGE genes in cutaneous melanoma. Sixteen of 100 primary tumors vs. 69 (48%) of 145 metastases from individual patients expressed MAGE-1. Similar differences in the frequency of gene expression between primary and metastatic tumor samples were observed for MAGE-2, MAGE-3, and MAGE-4. MAGE expression in primary tumors was correlated with tumor thickness: there was a significantly increased frequency in the expression of MAGE-1, -2 and -3 in tumors of greater thickness. Benign and dysplastic nevi, as well as in situ melanomas, did not express any of the 4 MAGE genes.
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
September 1997,
Clinical & experimental metastasis,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
July 1997,
Journal of immunotherapy (Hagerstown, Md. : 1997),
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
April 2007,
The British journal of dermatology,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
August 2013,
Seminars in oncology nursing,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
February 1998,
Melanoma research,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
January 2003,
Cancer genetics and cytogenetics,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
April 2023,
The Journal of investigative dermatology,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
September 2003,
Ai zheng = Aizheng = Chinese journal of cancer,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
October 2021,
Annals of dermatology,
F Brasseur, and
D Rimoldi, and
D Liénard, and
B Lethé, and
S Carrel, and
F Arienti, and
L Suter, and
R Vanwijck, and
A Bourlond, and
Y Humblet
March 2012,
The British journal of ophthalmology,
